Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 60760-767

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 60760-767). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

767-15 (Cyclobenzaprine 767 15)

Packaging label for Cyclobenzaprine Hydrochloride Tablets USP 10 mg, with a quantity of 15 tablets per package. The label shows the product NDC 60760-767-15 and indicates it is manufactured by Rubicon Research Private Limited, India, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label includes placeholders for lot number and expiration date, along with storage instructions to keep at controlled room temperature (15°-30°C, 59°-86°F).*

FDA Label Image

Image (Cyclobenzaprine HCl Tabs Structure)

Chemical structure of cyclobenzaprine hydrochloride, showing the molecular framework including aromatic rings and a side chain with nitrogen and hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.